; mean ± s.e.m., two-way ANOVA, * * P < 0.01; * * * P < 0.001; NS, not significant). (e) Haematoxylin and eosin (H&E) staining of CPs from Mcre;NICD1 and wild-type (WT) mice at P0 and P14. Note that CP epithelium exhibits the 'hobnail' configuration (arrowhead), whereas the enlarged CPs in Mcre;NICD1 mice are 'flattened' on ventricular surfaces (arrow). Vesicular sac with accumulated CSF is shown (asterisk). Scale bars, 500 µm (white) and 25 µm (black). (f) H&E staining of human CP papilloma (CPP) and normal CP. Scale bar, 25 µm. (g) qRT-PCR analysis of Hes1 and Hes5 expression in CP tumours (black circles) and wildtype CPs (white circles) at P0, P7, P14 and P21 (data from technical replicates of each specimen set in a single experiment are shown; experiment was not repeated; raw data can be found in Supplementary Table 9 ). atonal homologue 1 (Atoh1, also known as Math1) and the roof plate, characterized by the expression of Wnt1, Gdf7 and the transcription factor Lmx1a (ref. [18] [19] [20] [21] . Some Lmx1a + cells are present in the rhombic lip and contribute to the cerebellum 20, 21 . To determine whether rhombic lip progenitors contribute to the roof plate/CP lineage, we used Math1-Cre to drive Cre expression in Atoh1 + progenitors 22 (Fig. 1a ). When crossed with the Rosa26-EYFP Cre reporter strain 23 , the resulting Math1-Cre;Rosa26-EYFP mice have cells expressing enhanced yellow fluorescent protein (EYFP) in the CP in addition to the cerebellum (Fig. 1b ). Although these EYFP + cells comprise <0.5% of hindbrain CP epithelium, they express CP markers Lmx1a, orthodenticle homeobox 2 (Otx2), cytokeratins and aquaporin 1 (Aqp1; Fig. 1c,d and Supplementary Fig. 1a ), indicating that some Atoh1 + progenitors contribute to hindbrain roof plate/CP lineage.
To determine the effects of Notch signalling on CP, Math1-Cre;Rosa26-EYFP mice were crossed with a Rosa26-NICD1 strain that Supplementary Table 9 ; mean ± s.e.m., two-way ANOVA, * * * * P < 0.0001). (c) The expression of Ki-67 and Cdkn1b (p27 Kip1) is shown in tumours from Mcre;NICD1 mice and wild-type (WT) CPs at P7. Note that staining for Ki-67 and p27 is mutually exclusive, and p27 or Ki-67 expression is absent in wild-type CP epithelium despite positive staining in the cerebellum (Cb Table 9 ; experiment was not repeated for Ttr expression; Aqp1 expression analysis was repeated in one independent experiment). (f) Western blot analysis of Aqp1 and Otx2 expression in CP tumours and wild-type (WT) CPs at P14. β-actin serves as the loading control. Molecular size markers and representative unprocessed original scans of blots can be found in Supplementary Fig. 9 .
conditionally expresses the intracellular domain of Notch1 (NICD1) and green fluorescent protein 24 (GFP, Fig. 1a ). In Math1-Cre;Rosa26-NICD1;Rosa26-EYFP animals, hindbrain CP is significantly enlarged with many EYFP + cells ( Fig. 1b ). Sustained NICD1 expression in Atoh1 + lineage leads to >50-fold increase (∼50%) in its contribution to hindbrain CP epithelium at birth that peaks at postnatal day 14 (P14; ∼80%; Fig. 1d and Supplementary Fig. 1a ). Wild-type CP epithelium exhibits an orderly cobblestone-like appearance with a rough, 'hobnail' configuration on apical surfaces, whereas CPs from Math1-Cre;Rosa26-NICD1 (Mcre;NICD1) mice are characterized by papillary projections lined by flattened epithelium with cell crowding, elongation and stratification, reminiscent of human CP papilloma (Fig. 1e,f and Supplementary Fig. 1b ). When the Rosa26-NICD1 strain was crossed with Lmx1a-Cre transgenic mice that express Cre in the roof plate/CP lineage 20 , abnormal CP growth with identical characteristics developed in the lateral ventricles and hindbrain of Lmx1a-Cre;Rosa26-NICD1 (Lcre;NICD1) animals ( Supplementary  Fig. 2 ). Although these abnormal CP growths do not invade surrounding regions, CSF accumulation and ventricular dilation are present in these animals ( Fig. 1e and Supplementary Figs 1b and 2), and 40-50% of Lcre;NICD1 animals die from hydrocephalus. CP tumours of Mcre;NICD1 mice exhibit increased expression of Hes1 and Hes5, indicating Notch pathway activation ( Fig. 1g and Supplementary Fig. 1c,d ). No Ki-67 expression is detected in wild-type CP epithelium at P7, whereas abundant Ki-67 + cells are present in CPs from age-matched Mcre;NICD1 or Lcre;NICD1 mice, resembling cell proliferation in human CP tumours ( Fig. 1h ), indicating that Notch pathway activation causes aberrant growth of CP into tumours.
Enhanced proliferation in Notch-induced CP tumour
Although CP epithelial cells in wild-type and Math1-Cre;Rosa26-EYFP mice (EYFP + or EYFP − ) remain post-mitotic after birth,
This percentage gradually decreases to ∼1% after 3 weeks of age ( Fig. 2a,b and Supplementary Fig. 3a ). EdU (5-ethynyl-2deoxyuridine) incorporation assays also revealed enhanced tumour cell proliferation in Mcre;NICD1 mice ( Supplementary Fig. 4a ). As tumour cells exit the cell cycle, Ccnd1 expression is downregulated, whereas Cdkn1b (p27 Kip1) expression is upregulated ( Fig. 2c and Supplementary Fig. 4b,c ). Cleaved caspase-3 expression is not detected ( Supplementary Fig. 4d ). Together, these results indicate that Notchinduced CP tumour undergoes enhanced proliferation transiently after birth. Tumour cells express the CP marker Lmx1a, but not the mesenchymal marker MafB (ref. 25) , and the expression of Aqp1, transthyretin (Ttr), cytokeratins and Otx2 is consistently reduced compared with CP epithelial cells 26 (Fig. 2d-f and Supplementary Figs 3b and 4e,f), indicating that sustained Notch signalling interferes with differentiation of tumour cells even after they become post-mitotic.
Abnormal Shh signalling in CP tumour cells
To identify signals that drive tumour cell proliferation, we compared transcriptional profiles of tumours and wild-type CPs at P0 (tumour cells are proliferative) and P21 (tumour cells are post-mitotic) using RNA-seq. Tumours and CPs clustered separately in principal component analysis, indicating distinct molecular profiles ( Fig. 3a ). Tumour cells exhibit gene expression profiles defined by differential expression of 2,738 (P0) and 4,964 (P21) transcripts (Supplementary Table 1 and Fig. 3b ). Study of these differentially expressed transcripts identified 1,705 common targets, including Hes1 and Hes5, Aqp1, cytokeratins and Otx2, all of which show significant differential expression by quantitative PCR with reverse transcription (qRT-PCR) and immunostaining analyses, validating RNA-seq results (Figs 1g,  2d-f and 3d,e and Supplementary Figs 1c,d, 3b and 4e and  Supplementary Table 1 ). Although tumour cells express higher messenger RNA levels for roof plate markers Lmx1a, Gdf7, Zic3, Zic4 and Msx2, the expression of many genes found in CP epithelium is significantly lower [27] [28] [29] [30] [31] [32] (Fig. 3c,e and Supplementary Table 1 ).
Comparison of tumour expression profiles at P0 and P21 uncovered 4,910 differentially expressed transcripts ( Fig. 3b and Supplementary  Table 2 ). We reasoned that differential genes unique to P0 tumour cells may include those involved in proliferation. To identify these genes, we excluded the 1,705 common differential targets between tumours and CPs at each time point to obtain 1,033 differential transcripts in tumours at P0 (Fig. 3b ). We overlapped these 1,033 unique targets with the 4,910 differential genes between tumours of P0 and P21, further narrowing it down to 663 genes ( Fig. 3b and Supplementary Table 3 ). Interrogating this shortened list of genes using ingenuity pathway analysis led us to a promising candidate: Shh signalling, which is also identified in analysis of the larger data set ( Supplementary Tables 1 and 3 ). Tumour cells exhibit increased expression of Gli1, Gli2, Mycn and Ccnd1 compared with wild-type CP epithelium at P0 and P7. After P7, when tumour cells start to exit the cell cycle, the expression of these genes decreases to levels of those in control CPs, suggesting that decreased proliferation correlates with attenuated Shh signalling ( Fig. 3d -f,h,i and Supplementary Fig. 4b ).
In addition, the expression of p27 and Cdkn2b is upregulated in nonproliferating tumour cells, whereas Cdkn1c (p57 Kip2) is expressed at higher levels in mature CP ( Fig. 2c and Supplementary Fig. 4c and Supplementary Table 1 ). Among hedgehog ligands, only Shh is abundantly expressed in hindbrain CP epithelial cells at birth and declines to undetectable levels after P14, resulting in lower expression levels in tumours than in wild-type CPs at P0 ( Fig. 3d ,e,g,i).
Shh drives CP tumour cell proliferation
To determine the role of Shh signalling in Notch-induced CP tumours, we treated tumour cells with a recombinant amino-terminal fragment of Shh (ShhN). Tumour cells formed spheres under serum-free conditions and continued to express Lmx1a, indicating intact lineage characteristics under these conditions ( Fig. 4a ,c). After 96 h, more Ki-67 + cells were detected in tumour spheres treated with ShhN than in untreated tumour spheres ( Fig. 4b ). Although epithelial cells formed aggregates that remained unresponsive, the size of tumour spheres and number of tumour cells were increased by ShhN, including post-mitotic tumours at P21 or later, whereas the Smo inhibitor cyclopamine abolished such effects, indicating that ShhN stimulates tumour cell proliferation ( Fig. 4c,d ). To determine whether tumour growth requires Shh, we treated Lcre;NICD1 and Mcre;NICD1 animals with the Smo inhibitor vismodegib (100 mg kg −1 ) or vehicle daily from embryonic day 17.5 (E17.5) to P7, or from day E15.5 for 4 days, respectively 33, 34 . Vismodegib treatment shrank hindbrain CP tumours, significantly reduced the number of tumour cells, and improved the survival of Lcre;NICD1 mice ( Fig. 4e Supplementary Fig. 5 ). Together, these results indicate that Shh drives the growth of Notch-induced CP tumours. and wild-type (WT) CPs (white circles) at different time points (data from technical replicates of each specimen set in a single experiment are shown; experiment was repeated independently once with similar results; raw data can be found in Supplementary Table 9 ). (h) Western blot analysis of Ccnd1 expression in tumours and WT CPs. β-actin serves as the loading control (n = 1 specimen per genotype per time point, representative blot image from one of three independent repeated experiments is shown). Molecular size markers and representative unprocessed original scans of blots can be found in Supplementary Fig. 9 . (i) In situ hybridization analysis of Shh, Gli1 and Mycn expression in tumours and WT CPs. Shh expression is detected in epithelium (arrowheads), but absent in tumour cells (arrows) at P0, a pattern complementary to those of Gli1 and Mycn. Scale bar, 25 µm.
SHH and NOTCH signalling in human CP tumours
We examined NOTCH and SHH signalling in human CP tumours. First, we used published data sets and analysed tumour transcrip-tomes, epigenomes and genomes. Principal component analysis of human CPPs and normal CPs revealed distinct molecular profiles for CPPs (ref. 13 ; Fig. 4j ). MetaCore enrichment analysis of differential Supplementary Table 9 ; mean ± s.e.m., two-way ANOVA, * * * * P < 0.0001; NS, not significant). (e) Kaplan-Meier curve depicting the survival of Lcre;NICD1 mice treated with vismodegib (n = 22 animals) or vehicle (n = 19 animals). (f) Hindbrain CPs from day P7 Lcre;NICD1 mice treated with vismodegib (lower) or vehicle (upper). Scale bar, 1 mm. Quantification of tumour cells in treated animals is shown (n = 7 animals per treatment, raw data are available in Supplementary Table 9 ; mean ± s.e.m., two-tailed unpaired t-test, * * P < 0.01). (l) Venn diagram shows the overlap of differential genes (FDR < 0.05) between human CPPs and normal CPs (A), with those between murine tumours and wild-type CPs at P21 (B, n = 3 specimens per genotype) and P0 (C, n = 3 specimens per genotype). (m) MetaCore analysis of overlapping genes between mouse and human CPPs shown in l. (n) qRT-PCR analysis of gene expression in human CP tumours (CPP: n = 7 tumours from seven individuals; CPC: n = 2 tumours from two individuals). Values represent fold changes relative to human CP epithelium. Data shown are derived from a single experiment, available in Supplementary Table 9 and not repeated. genes in human CPPs placed NOTCH and SHH signalling among significantly enriched pathways ( Fig. 4k and Supplementary Table 4 ). Second, we repeated gene expression profiling of CP tumours in Mcre:NICD1 animals and wild-type CPs at P0 and P21 using a similar microarray approach. The differentially expressed genes in murine CPPs overlapped with those identified in human CPPs (Fig. 4l ).
MetaCore analysis of these common differential transcripts between murine and human CPPs revealed significant enrichment for genes in both pathways, indicating that murine CPPs exhibit a striking resemblance to human CPPs ( Fig. 4m and Supplementary Table 5 ). Third, we examined data sets from recently published studies of human CP tumours and found higher expression levels of roof plate markers in CPPs compared with CPCs (refs 14,15; Supplementary Fig. 6a ). MetaCore gene expression analysis showed significant enrichment for SHH and NOTCH pathways in human CPCs, an observation also supported by analysis of methylation and copy number variation data ( Supplementary Fig. 6b-d and Supplementary Table 6 ). qRT-PCR analysis of human CP tumours revealed increased expression for genes of both pathways in CP tumours compared with normal human CP epithelial cells (Fig. 4n ). In situ hybridization demonstrated SHH mRNA in both CPPs and CPCs (percentage of SHH -positive cells in CPP: 24.82 ± 3.32, n = 11 specimens examined from 10 individuals; CPC: 36.33 ± 5.40, n = 10; disease-free control: 100%; n = 5; of note, signal strength varied among samples, most likely owing to brain regions sampled, specimen age and storage; Supplementary Fig. 6e ).
Together, these results indicate that human CP tumours exhibit aberrant NOTCH and SHH signalling, suggesting that both pathways may play a similarly important role in human CP tumorigenesis.
Notch-induced CP tumour cells are monociliated
In vertebrates, Shh-driven signalling occurs through the primary cilium 16, 17 . To understand the mechanisms by which tumour cells with sustained Notch signalling respond to Shh, we examined primary cilia in CP tumour and epithelial cells. Transmission electron microscopy and staining for the cilia markers ADP-ribosylation factor-like 13b (Arl13b; ref. 35 ), γ-tubulin and acetylated α-tubulin revealed multiple short primary cilia in wild-type and EYFP + epithelial cells in Math1-Cre;Rosa26-EYFP mice, whereas a single, longer primary cilium is present in tumour cells (epithelial cells: 1.70 ± 0.11 µm, n = 10; tumour cells: 3.78 ± 0.13 µm, n = 12; two-tailed unpaired t-test, P < 0.0001; data from a single experiment are shown, raw data are available in Supplementary Table 9 ; Fig. 5a -c and Supplementary Fig. 7a,b ). Gene expression profiling showed that many genes involved in ciliogenesis are downregulated in tumour cells [36] [37] [38] (Fig. 5d ). The expression of forkhead box J1 (Foxj1) and multiciliate differentiation and DNA synthesis associated cell cycle protein (Mcidas), two crucial regulators of the differentiation of cells with numerous motile cilia [39] [40] [41] , is consistently reduced in tumour cells ( Fig. 5e and Supplementary Fig. 7c ), indicating that Notch signalling suppresses Mcidas and Foxj1 expression, and blocks multiciliate differentiation of tumour cells. Similar to tumour cells, progenitors in hindbrain roof plate exhibit increased expression of Hes1 and Hes5 at day E14.5, and possess single primary cilium (Fig. 5f,g and Supplementary Fig. 7d,e ), suggesting that active Notch signalling preserves the single primary cilium of the progenitors during development. We characterized cilia pattern in human CP tumours (17 CPPs and 13 CPCs). Compared with normal human CP epithelial cells with multiple cilia, most CPPs comprise either monociliated tumour cells alone or mixed populations of monociliated and multiciliated cells. In all CPCs examined, cilia observed in tumour cells were solitary primary cilia (Fig. 5h,i and Supplementary Fig. 7f ).
Monociliated CP tumour cells are uniquely capable of transducing Shh signals
To determine whether the distinct cilia pattern of tumour cells affects Shh signalling, we characterized Shh-driven Smo ciliary translocation. Both CP epithelial and tumour cells express Lmx1a when grown with serum; however, only tumour cells can proliferate (Fig. 6a,b and Supplementary Fig. 7g ). After serum removal, cells were treated with ShhN or SAG, a Shh pathway agonist 42 (Fig. 6a ). Although such treatment failed to promote ciliary accumulation of Smo in epithelial cells, it led to translocation of Smo into the solitary primary cilium of tumour cells (ShhN: n = 3, 71.78 ± 6.93%, P < 0.0001; SAG: n = 3, 74.99 ± 3.03%, P < 0.0001; two-way ANOVA; Fig. 6c,d) , even though both cell types express similar levels of Ptch1 and Smo (Fig. 6e) , indicating that Shh signalling in the primary cilium is preserved in tumour cells, but lost in epithelial cells despite their multiple primary cilia. Indeed, ShhN or SAG restored the percentage of Ki-67 + tumour cells after serum removal, an effect that can be reversed by cyclopamine, indicating that tumour cells are uniquely capable of responding to Shh through proliferation ( Fig. 6f-h) .
Notch-induced CP tumour arises from roof plate progenitors
The similarity in gene expression between tumour and roof plate cells, together with elevated Notch signalling and solitary primary cilium in the latter, suggests that Notch-induced CP tumour is related to the roof plate. To delineate the developmental origin of CP tumour, we first analysed the distribution of Atoh1 + progenitors in hindbrain roof plate using Math1 M1GFP mice with enhanced green fluorescent protein (EGFP) fused to the carboxy terminus of Atoh1 (ref. 43 ). In addition to the rhombic lip, Atoh1:EGFP + cells are present in the Lmx1a + /Otx2 + upper roof plate but largely absent from the lower roof plate ( Fig. 7a and Supplementary Fig. 8a ). Second, we analysed tumour formation in Mcre;NICD1 animals during development. At day E12.5, although many NICD1 + /GFP + cells are located in the rhombic lip bordering the Lmx1a + roof plate, some NICD1 + /GFP + cells are present within CP forming into papillary structures (Fig. 7b ). These prospective Lmx1a + tumour cells undergo proliferation (Ki-67 + ), and remain undifferentiated (Aqp1 − ; Fig. 7b and Supplementary  Fig. 8b) . At day E14.5, most NICD1 + /GFP + tumour cells are found in Lmx1a + upper roof plate and the rostral half of the CP (Fig. 7c ). Third, proliferative progenitors (Lmx1a + /Ki-67 + /Aqp1 − ) in hindbrain roof plate differentiate into post-mitotic epithelial cells that form the CP epithelium (Lmx1a + /Ki-67 − /Aqp1 + ) during embryogenesis 44, 45 . The shape and size of the roof plate are similar between wild-type and Mcre;NICD1 mice; however, tumour cells remain proliferative and undifferentiated (Ki-67 + /Aqp1 − ) even after their incorporation into CP epithelium ( Fig. 8a and Supplementary Fig. 8c ). Together, these results indicate that CP tumours in these animals arise from roof plate progenitors and migrate into the CP where they continue to undergo Shh-driven proliferation throughout development (Fig. 8b,c) .
DISCUSSION
In this study, we examined Notch signalling in CP tumours, a group of rare brain neoplasms most commonly found in children. Consistent with a role for NOTCH pathway in these tumours [8] [9] [10] [11] , analysis of human CP tumour data sets revealed significant enrichment for NOTCH signalling. Using animal models, we showed that sustained Notch1 signalling leads to CP tumours that, similar to human CP tumours, express CP markers and undergo increased proliferation. Cross-species molecular analysis demonstrates that these CP tumours closely resemble their human counterpart, validating our animal models as accurate representations of human disease. CP tumours are thought to originate from CP epithelium 14, 15 . Analysis of Math1-Cre;Rosa26-EYFP mice indicates that EYFP + Supplementary Table 9 ). Supplementary Table 9 ; mean ± s.e.m., two-way ANOVA, * * * P < 0.001; * * * * P < 0.0001). epithelial cells derived from Atoh1 + progenitors in the roof plate exhibit properties similar to the rest of the CP epithelium. Indeed, the identical CP tumours in Lcre;NICD1 and Mcre:NICD1 mice indicate that both Atoh1 + and Atoh1 − lineages in CP are sensitive to Notch signalling activation. However, despite the expression of CP markers, expression of many genes found in mature epithelium fails to be upregulated in tumour cells, suggesting a related but distinct developmental origin, or a block in differentiation, or both. The presence of Atoh1 + progenitors and nascent tumour cells from Mcre:NICD1 mice in the roof plate suggests that CP tumours arise from progenitors within this region 44, 45 . In agreement, tumour cells and these progenitors exhibit similar characteristics: increased expression of roof plate markers, elevated Notch signalling, and single primary cilium. The development of CP tumours induced by sustained Notch signalling may reflect its inherent role in roof plate/CP morphogenesis [46] [47] [48] [49] : the Notch pathway suppresses multiciliate and epithelial differentiation of progenitors, thereby preserving the primary cilium-based Shh signalling (Fig. 8b) . Compared with CPCs, human CPPs express higher levels of roof plate markers ( Supplementary Fig. 5a ), consistent with their developmental origin. We provide evidence that CP epithelial cells secrete Shh that drives the proliferation of a distinct population of Shh-responsive progenitors in the upper roof plate. Consistent with previous reports, we showed Shh expression in hindbrain CP epithelium at birth that gradually disappears within two weeks 50, 51 
. Interestingly, low-level cell proliferation and Mycn expression is detected in tumour cells from
Mcre;NICD1 animals at P14, presumably driven by residual or transvesicular Shh from other brain regions, as shown for CP-derived signals regulating distant cell populations in the brain [52] [53] [54] . Tissuespecific deletion may delineate the role of Shh from these sources in tumour growth 25, 50 .
Analysis of published data sets demonstrated enrichment for SHH signalling, suggesting a role for deregulated SHH expression in human CP tumours, including CPCs (refs 13-15 ). Consistently, tumours from
Mcre;NICD1 or Lcre;NICD1 mice exhibit active proliferation similar to that observed in CPCs at P0 when Shh is robustly expressed. Our results suggest that Shh pathway inhibition may represent a viable strategy for targeted therapy for CP tumours. SHH pathway inhibitors, clinically approved for treating other more common cancer types, may be 'repurposed' for treating patients with CP tumours exhibiting abnormal SHH signalling. Indeed, vismodegib treatment interferes with tumour progression in our models, although further validation with xenograft models would be necessary. The tumour becomes quiescent as Shh expression decreases, suggesting that additional changes are present to support aggressive growth of CP tumours as seen in human CPCs with aberrant NOTCH signalling. Tumour cells proliferate in the presence of serum ( Fig. 6b and Supplementary Fig. 7g ), indicating that serum may contain factors capable of driving tumour growth. Amplifications of TAF12, NFYC and RAD54L play an important role in CPCs (ref. 15 ). Their expression is not significantly changed in our CP tumours; however, deregulation of these genes may alter the behaviour of Notch-induced CP tumours. TP53 alterations play a crucial role in human CPCs (ref. 6, 14) . CP tumours in our models retain the wild-type Tp53 and exhibit signs of Tp53 signalling and DNA damage response (Supplementary Tables 1-3 and 5 and Fig. 4m ), suggesting that Tp53 loss may facilitate malignant transformation of Notch-induced CP tumours.
Aberrant NOTCH signalling has been linked to different cancers in humans and therapeutically targeted [55] [56] [57] . The single primary cilium on tumour cells with constitutive Notch signalling proves to be essential for Shh signalling, whereas multiple primary cilia may interfere with cilium-dependent signalling activities [58] [59] [60] [61] . A Notch-regulated signalling cascade involving Mcidas, Myb and Foxj1 plays an important role in the differentiation of cells with multiple motile cilia [39] [40] [41] [62] [63] [64] . Our results reveal that the interaction between Notch signalling and primary cilia is crucial for CP tumorigenesis (Fig. 8c) : sustained Notch signalling preserves the single primary cilium by suppressing Mcidas and Foxj1 expression to block multiciliate differentiation, transforming progenitors into tumour cells that undergo Shh-driven proliferation. Targeting Notchmediated multiciliate differentiation may represent a rational strategy for CP tumour treatment. Human CP epithelial cells exhibit a 'hobnail' contour on the apical side, whereas the surface of CP tumour cells is more flattened 9, 65 . Our results suggest that the cilia pattern of tumour cells may mediate this distinct morphology. Indeed, most human CP tumours (including all CPCs) exhibit solitary primary cilium. Understanding the interaction between Notch signalling, ciliogenesis and epithelial differentiation in CP tumours is essential to validate the therapeutic potential of Notch inhibitors.
METHODS

Methods and any associated references are available in the online version of the paper.
Note: Supplementary Information is available in the online version of the paper METHODS Mice. Gt(ROSA)26Sor tm1(Notch1)Dam /J (Rosa26-NICD1) mice, B6.129X1-Gt(ROSA)26Sor tm1(EYFP)Cos /J (Rosa26-EYFP) mice, B6.129S-Atoh1 tm4.1Hzo /J (Math1 M1GFP ) mice, B6.Cg-Tg(Atoh1-cre)1Bfri/J (Math1-Cre) transgenic mice, and C57BL/6 mice (all from Jackson Laboratory), and Tg(Lmx1a-cre)1Kjmi (Lmx1a-Cre) transgenic mice were maintained by breeding with C57BL/6 mice. Experimental procedures on animals housed at Sanford Research were approved by Sanford Research Institutional Animal Care and Use Committee and performed in compliance with national regulatory standards. No statistical method was used to predetermine sample size in animal experiments. The animal experiments were not randomized. The investigators were not blinded to group allocation during experiments and outcome assessment. Experimental animals were administered 100 mg kg −1 vismodegib (LC laboratories, V-4050) or vehicle following two regimens: daily treatment from day E15.5 to E18.5 (Mcre;NICD1 mice: 10 animals for each treatment); or from day E17.5 to day P7 (Lcre;NICD1 mice: 29 animals for vismodegib, 26 animals for vehicle), by gastric gavage of pregnant or nursing females.
Human samples. Human CP specimens were procured with informed consent from human subjects following the requirements by institutional review boards at Sanford Research, Sanford Burnham Prebys Medical Discovery Institute, and Ludwig-Maximilans-University. All CP specimens from Boston Children's Hospital were obtained under an approved institutional review board protocol (Supplementary Table 7 ). Normal human CP epithelial cells (ScienCell) were used as the control in gene expression analysis. All tissues were handled in accordance with guidelines and regulations for the research use of human brain tissue set forth by the NIH (http://osp.od.nih.gov/office-clinical-research-and-bioethics-policy). Diagnoses of human CP specimens from Boston Children's Hospital were reviewed by two neuropathologists (H.G.W.L., S. Santagata) using standard WHO criteria 66 .
Isolation and culture of primary CP cells. Multiple sets of CP specimens from
Mcre;NICD1 and/or wild-type mice were collected. To obtain sufficient numbers of cells, each set of specimens included tissues pooled from multiple animals of the same genotype. Gender information is not available for animals at P0 and P7. Both male and female animals were used at other time points (see Supplementary  Table 9 for information on animals used for each experiment). Dissected CP specimens were dissociated with forceps under a stereoscope followed by enzymatic digestion at 37 • C for 20 min in 0.7 mg ml −1 of hyaluronic acid (H3506, Sigma-Aldrich), 0.2 mg ml −1 of kynurenic acid (Sigma-Aldrich K3375), and 1 mg ml −1 of trypsin in Hank's balanced salt solution (HBSS, 14170-112; Life Technologies) supplemented with 2 mM glucose. The trypsin inhibitor ovomucoid (LS003085, Worthington Biochemical Corporation) was added to stop enzymatic digestion and dissociated CP cells were centrifuged at 200g for 5 min at 4 • C. Cell pellets were resuspended in Dulbecco's modified Eagle's medium/Nutrient Mixture F-12 Ham's-Liquid Media (DMEM/F12, SH30271; Thermo Fisher Scientific), and cultured in DMEM/F12 supplemented with 30 ng ml −1 of EGF (Sigma-Aldrich E4127), 30 ng ml −1 of FGF2 (Sigma-Aldrich F0291), B27 supplement, 2 mM glutamine, and 100 U ml −1 penicillin/streptomycin (all from Life Technologies). After treatment under serum-free conditions for 96 h, cells were dissociated mechanically by pipetting and quantified. For culture with serum, medium was supplemented with 10% fetal bovine serum. Cytosine β-D-arabinofuranoside (Ara-C, 20 µM; Sigma-Aldrich C1768) was added the following day to eliminate contaminating fibroblasts. Cultured cells were treated with ShhN (ref. 67; 200 ng ml −1 ), or SAG (200 nM; 11914, Cayman Chemical Company), with or without cyclopamine (10 µM; LC laboratories C-8700). Primary CP tumour or epithelial cells were not listed in the database of commonly misidentified cell lines maintained by ICLAC and NCBI Biosample. Analyses of gene expression, proliferation and signal transduction were performed in cultured primary CP cells (Figs 4a-d  and 6b -d,f-h and Supplementary Fig. 7g) . Results from these studies confirmed their identity. Given the short time (<8 days) during which CP cells were maintained as primary cultures supplemented with antibiotics, we did not test for mycoplasma contamination.
Histology, immunohistochemistry, immunofluorescence and immunocytochemistry. Whole brains were fixed overnight in 4% paraformaldehyde (PFA) and processed for paraffin embedding and sectioning. Tissue sections were deparaffinized with CitriSolv (Decon Labs), and then rehydrated with graded ethanol series. For frozen tissues, samples were further equilibrated in 20% sucrose at 4 • C for 24-48 h, embedded in Tissue-Tek Optimal Cutting Temperature (O.C.T.) compound (Sakura Finetek), and sectioned (15-20 µm thickness) on a cryostat. Cultured cells were fixed in 4% PFA at room temperature for 10 min and stored in phosphate-buffered saline (PBS). For primary cilia staining, cells were fixed with cold methanol for 10 min and stored in PBS at 4 • C.
No randomization was used to determine how samples were allocated to experimental groups and processed. Immunostaining was carried out as described previously 67 . Heat-induced epitope retrieval was performed for paraffin-embedded tissue sections in Rodent Decloaker (Biocare Medical). For immunohistochemistry, endogenous peroxidase activities were inactivated in 3% H 2 O 2 for 10 min at room temperature. Tissue sections were blocked with 10% normal sera in PBS-0.1% Triton X-100 for 1 h at room temperature and incubated with primary antibodies for 1 h. After washes with PBS, biotinylated secondary antibodies were applied for 1 h, followed by treatment with avidin/biotinylated enzyme complex and substrate/chromogen incubation (Vector laboratories). Slides were counterstained with haematoxylin. For immunofluorescence, tissue sections or cells were sequentially probed with primary antibodies and fluorescently labelled secondary antibodies (Jackson Immunoresearch). Primary antibodies used and dilution ratios are: mouse monoclonal anti-acetylated α-tubulin (1:500, ab24610, clone 6-11B-1, abcam), mouse monoclonal anti-acetylated α-tubulin (1:500, Sigma-Aldrich T7451, clone 6-11B-1), mouse monoclonal anti-Arl13b (1:500, clone N295B/66, NeuroMab), rabbit anti-Arl13b (1:500, 17711-1-AP, Proteintech), mouse monoclonal anti-aquaporin 1 (1:1,000, clone 1/22, abcam ab9566), rabbit antiaquaporin 1 (1:1,000, AB2219, EMD Millipore), rabbit monoclonal anti-cleaved caspase-3 (Asp175; clone 5A1E; 1:800, 9664, Cell Signaling Technology), mouse monoclonal anti-Ccnd1 (1:100, sc-450, clone 72-13G, Santa Cruz Biotechnology), mouse monoclonal anti-Cdkn1b (p27 Kip1; 1:100, 610242, clone 57/Kip1/p27, BD Biosciences), rabbit anti-cytokeratins (1:100, Z0622, Dako, Carpinteria), mouse monoclonal anti-Foxj1 (1:50, 14-9965, Clone 2A5, eBioscience), chicken anti-GFP (1:1,000, GFP-1010, Aves Lab), mouse monoclonal anti-γ-tubulin (Sigma-Aldrich T6557, clone GTU-88, 1:10,000), guinea pig anti-Hes1 For primary cilia staining of CP specimens from mice, the cilia pattern was assessed by analysing three distinct tissue regions of each animal. To measure the length of primary cilia, 12 primary cilia from tumour cells and 10 primary cilia from epithelial cells were examined. Smo ciliary translocation was assessed by analysing three distinct fields: the percentage of cells with ciliary accumulation of Smo was calculated by averaging the number of cells with Smo translocation per 100 cells of all samples for each treatment. Information on animals used for each experiment can be found in Supplementary Table 9 .
For staining of primary cilia in human CP tumours and normal human CPs, the investigator was blinded to group allocation. Tissues used include: normal CP: 6 disease-free individuals; CPP: 17 tumour specimens from 16 individuals; CPC: 13 tumours from 10 individuals ( Supplementary Table 9 ). Cilia staining was assessed by analysing 5 distinct tissue regions.
EdU (5-ethynyl-2 -deoxyuridine) incorporation assay.
One hour after intraperitoneal injection of 100 mg kg −1 EdU (7180, Setareh Biotech), whole brains were collected from animals. Tissue sections were rinsed with Tris-buffered saline (TBS) and then incubated for 20 min with a solution consisting of 100 mM pH 8.5 Tris, 1 mM CuSO 4 , 10 mM Cy5-azide (B3030, Lumiprobe) and 100 mM ascorbic acid. Information on animals used is provided in Supplementary Table 9 .
Image acquisition. Whole-mount images were obtained using a Nikon SMZ1000 stereomicroscope. Light and fluorescent microscopic images were obtained by a Nikon Eclipse 90i microscope system or a Nikon confocal microscope system A1 + .
Transmission electron microscopy. CP specimens were collected at different time points. To ensure collection of a sufficient amount of normal CP specimens, each normal CP specimen includes tissues pooled from two wild-type animals for P7, P14 and P22. Information on animals used is available in Supplementary Table 9 . The investigator was blinded to group allocation. Tissues were fixed in 4% PFA, 1% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4) at 4 • C overnight. After washing DOI: 10.1038/ncb3327 with cacodylate buffer supplemented with 10% sucrose, tissues were post-fixed with 1% osmium tetroxide (OsO 4 ), followed by incubation with 1% uranyl acetate in 30% ethanol. Tissue samples were dehydrated, then transferred to propylene oxide, and embedded in Eponate-12 epoxy resin (Ted Pella). Tissue samples were sectioned (85 nm thickness) with a Leica UC-6 ultramicrotome. Sections were counterstained with uranyl acetate and lead citrate, and observed under the JEOL 1400 transmission electron microscope (JEOL). Images were taken with a Gatan UltraScan 1000 CCD (charge-coupled device) digital camera (Gatan).
Immunoblotting. Immunoblotting was carried out as described previously 67 . Multiple sets of CP specimens were collected at each time point. To obtain a sufficient quantity of protein, each set of specimens may contain tissues pooled from several animals of the same genotype. Gender information is not available for animals at P0 and P7 (see Supplementary Table 9 for information on animals used). Tissues were homogenized in protein lysis buffer (Tris/HCl pH 7.4, 1 mM EDTA, 150 mM NaCl, 1% NP40, 0.25% sodium deoxycholate, 1× protease inhibitor cocktails (Research Product International)). Protein concentrations were measured by a standard BCA assay (Life Technologies). Equal amounts of protein were resuspended in a reduced sample buffer, separated by SDS-PAGE, and then transferred to a polyvinylidene difluoride membrane. After incubation with 5% non-fat milk in TBST (TBS, 0.5% Tween 20) for 1 h, the membrane was incubated with primary antibodies for 1 h. The membrane was washed and incubated with horse radish peroxidase (HRP)-conjugated secondary antibodies (GE Healthcare) for 1 h. After washes, chemiluminescence detection was performed using Western Lightning Plus-ECL (PerkinElmer). β-actin was used as a protein loading control. Primary antibodies used include: mouse monoclonal anti-β-actin (Sigma-Aldrich A5441, clone AC-15, 1:2,000), rabbit anti-aquaporin 1 (EMD Millipore AB2219, 1:1,000), mouse monoclonal anti-Ccnd1 (Santa Cruz sc-450, clone 72-13G, 1:200), rabbit anti-Hes1 (R. Kageyama, 1:1,000), rabbit anti-Otx2 (EMD Millipore AB9566, 1:500).
RNA preparation, quantitative RT-PCR, in situ hybridization, microarray, and RNA-seq. For murine tissues, three independent sets of tumour specimens from Mcre;NICD1 mice and three sets of CP specimens from wild-type mice were collected at each time point. To ensure that a sufficient amount of RNA can be extracted, each set of specimens included tissues pooled from several animals of the same genotype. Gender information was not available for animals at P0 and P7 (see Supplementary Table 9 for information on animals used for each set of specimens). For human tissues, seven CPPs from seven individuals, two CPCs from two individuals, and normal human CP epithelial cells (ScienCell) were used (Supplementary Table 9 ). Total RNA was extracted using Trizol and PureLink RNA Mini Kit (Life Technologies) according to the manufacturer's instructions. For quantitative PCR with reverse transcription (qRT-PCR), total RNA samples were converted to cDNA using the GoScript Reverse Transcription System (Promega). All reactions were set up in triplicate with ABsolute Blue QPCR Mix (Thermo Fisher Scientific) and run on an ABI 7000 Sequence Detection System (Life Technologies). Gene-specific primers and probes for mouse Aqp1, Ttr, Gli1, Mycn, Shh, Ptch1, Smo, Hes1, Hes5, Foxj1, Mcidas and control Actinb were used (Supplementary Table 8 ).
The following Taqman assays for human genes were used (Life Technologies): GLI1 (Hs01110766_m1), PTCH1 (Hs00181117_m1), MYCN (Hs00232074_m1), HES5 (Hs01387463_g1), HES1 (Hs00172878_m1), HEY1 (Hs01114113_m1), ACTB (Hs99999903_m1). Data were analysed using ABI Fast System SDS software. Transcript levels were determined as the number of transcripts for each gene relative to those of Actb (mouse) or ACTB (human). The results for each set of specimens were obtained by averaging transcript levels of technical triplicates and used for subsequent analyses. Data from qRT-PCR experiments can be found in Supplementary Table 9 . Exclusion was applied only on rare occasions when one of the three wells of the triplicate was a significant outlier; however, for each sample in question, qRT-PCRs were repeated in independent experiments, which validated the exclusion.
In situ hybridization was performed by RNA In Situ Hybridization Core facility at Baylor College of Medicine as described previously 69 . For analysis of Shh, Mycn and Gli1 expression, CP specimens from multiple animals were collected at P0 and P14. For analysis of Mycn expression in Mcre;NICD1 animals treated with vismodegib or vehicle, three tumours from three vismodegib-treated mice, and five tumours from five vehicle-treated mice were examined at P0. For Hes1 and Hes5 expression analysis, two Mcre;NICD1 mice and one wild-type mouse were collected at day E14.5. Gender information was not available for embryos, P0 animals, and the P8 animal for sense probe controls (see Supplementary  Table 9 for information on animals used for each experiment). For human tissue samples, SHH (probe no. 600951), PPIB (positive control, probe no. 313901), dapB (negative control, probe no. 310043) RNA were visualized using RNAscope 2.0 HD detection kit-BROWN (Advanced Cell Diagnostics) according to the manufacturer's protocol. Human tissues used include: normal CP: 5 disease-free individuals; CPP: 11 tumour specimens from 10 individuals; CPC: 10 tumours from 10 individuals (Supplementary Tables 7 and 9 ). SHH expression was assessed in five distinct tissue regions: percentage of SHH -expressing cells was calculated by averaging the numbers of SHH + cells per 100 cells in five distinct tissue regions of each specimen.
Microarray and RNA-seq studies were performed at the DNA Analysis Core at Sanford Burnham Prebys Medical Discovery Institute. For microarray experiments, labelled cRNA was prepared from 500 ng RNA using the Illumina RNA Amplification Kit from Ambion (Life Technologies). The labelled cRNA (1,500 ng) was hybridized overnight at 58 • C to the Sentrix MouseWG-6 Expression BeadChip (>46,000 gene transcripts; Illumina) according to the manufacturer's instructions. BeadChips were subsequently washed and developed with fluorolink streptavidin-Cy3 (GE Healthcare). BeadChips were then scanned with an Illumina BeadArray Reader. tumourPathway analysis using the GeneGo MetaCore Analytical Suite (http: //genego.com; GeneGo) was used to score and rank pathways enriched in data sets by the proportion of pathway-associated genes with significant expression values.
For RNA-seq experiments, total RNA samples were ribo-depleted using the Ribominus Eukaryote System (Life Technologies), and used to generate sequencing libraries of barcoded fragment using the Ion Total RNA-Seq Kit V2 (Life Technologies). Libraries were sequenced on the Ion Proton sequencer, three libraries per Ion Proton PI Chip, using 200 bp sequencing reagents. Reads were aligned to the mouse genome (mm10) using a combination of Tophat2, and Bowtie2 (http: //tophat.cbcb.umd.edu). Differentially expressed transcripts were detected using the Cufflinks Cuffdiff package (http://cufflinks.cbcb.umd.edu) and transcripts with a q value <0.05 (Cuffdiff) were analysed by ingenuity pathway analysis (Ingenuity Systems). Principal component analysis was performed using R package rgl (http:// cran.r-project.org/web/packages/rgl/index.html), a three-dimensional visualization system based on OpenGL. Hierarchical clustering was performed using Genesis (http://genome.tugraz.at/genesisclient/genesisclient_description.shtml).
Statistical analysis and reproducibility.
Statistical analyses were performed with GraphPadPrism 6.0 (GraphPad Software). All pooled data were expressed as the mean ± s.e.m. Differences between two groups were compared using an unpaired two-tailed t-test. Differences between multiple groups were analysed with one-way or two-way ANOVA followed by Tukey's multiple comparisons test. Results were considered significant at P < 0.05( * ); P < 0.01( * * ); P < 0.001( * * * ); P < 0.0001( * * * * ).
For western blotting, analyses of the expression levels of Aqp1 and Otx2 at P14, and Hes1 expression at P0 and P7, were repeated in one independent experiment. Analyses of the expression levels of Hes1 at P90, and Ccnd1 expression were repeated in two independent experiments with similar results. RNA-seq and microarray studies were performed in single experiments. For in situ hybridization, analyses of Mycn expression in vismodegib-treated animals, and Mycn and Gli1 expression at P0 and P14, were repeated in one independent experiment with similar results. Analysis of Shh, Hes1 and Hes5 expression was performed in single experiments ( Supplementary Table 9 ). SHH expression analysis in human tissues was conducted in one experiment with samples divided into two groups. For qRT-PCR analysis, the expression of Hes1, Hes5, Ttr, Ptch1, Smo and Mcidas was examined in single experiments, whereas Aqp1, Gli1, Mycn, Shh and Foxj1 expression analysis was repeated in one independent experiment with similar results. qRT-PCR analysis of human samples was performed in a single experiment. Analyses of cell proliferation (Ki-67 or EdU staining), percentage of EYFP + or GFP + cells in CP epithelium, tumour cell numbers, and Smo translocation were performed in single experiments. The measurement of cilia length was repeated in one independent experiment with similar results. Representative images were selected from two independent experiments. Accession numbers. Published human CP tumour data sets (GSE14098, GSE60886) were downloaded from GEO database for analysis. Data sets from our studies were deposited at NCBI. Sequencing: BioProject ID, PRJNA282889; Microarray: GSE77123. 
